Ann Dodds-Frerichs Email and Phone Number
I am a biopharmaceutical leader with expertise in regulatory affairs (clinical, non-clinical, CMC, operations), quality (GCP, GVP, GLP, GMP), and business operations with proven success driving timelines, strategy and execution for successful outcomes. I am known for creating high-level strategies with capacity for hands-on, tactical execution. As an approachable leader, I achieve performance excellence by leveraging vision, agility, and resources with a focus on empowerment and driving results. I have served as an advisor and chief of staff to executives on operational and regulatory risks, utilizing collaboration and active listening to engender support, align priorities, and reduce risks to produce innovative solutions. I tackle complex problems in a straightforward, efficient manner while addressing root causes to propel targeted results. As a high-performing regulatory and quality professional, I find it especially meaningful to contribute to the improvement of patients’ lives through innovation, discovery, and a commitment to quality. I am energized to continue delivering value to progressive, innovative, patient-centered organizations in the biotech and pharma industry. Key Strengths:• Regulatory Strategy – Effectively progress products through all phases of drug development, resulting in filing global marketing applications for nine novel products.• Dynamic Leadership – Exceptional aptitude to lead large, high-performing teams, through mentoring, empowerment, professional development, motivational management, and transparent communication.• Operational Excellence – Deliver targeted outcomes through collaboration, alignment, agility, and results driven approach in cross-functional matrixed environments. • Vendor Management – Proven track record of effective insourcing and outsourcing strategies, optimizing plans of action to achieve best value for company through sound vendor management that achieves competitive value, flexibility, and agility, while staying within or under budget.Skills:• GCP, GVP, GMP, GLP• Regulatory affairs• Regulatory operations• Quality and compliance• Change management• Strategic planning• Resource planning• Outsourcing and insourcing • Electronic systems (RIM, eCTD)• Regulatory project management• Document management• Partner and vendor management• Forecasting and planning• Budgetary management• Global submissions standards (FDA, Health Canada, EMA, ICH, GXP, eCTD)• IND, CTA, NDA, BLA, MAA, NDS
Dyne Therapeutics
View- Website:
- dyne-tx.com
- Employees:
- 40
-
Head Global Quality, Regulatory Cmc, And Regulatory OperationsDyne Therapeutics Dec 2023 - PresentWaltham, Massachusetts, United States -
Head, Global Safety And Reg Affairs Quality, Operations, Medical Writing, LabelingBiogen Oct 2018 - Sep 2023Led safety and regulatory operations, quality, medical writing, and labeling function comprised of approximately 80 employees and outsourced vendors. Administered $31M budget and directed six sub-functions: regulatory operations, regulatory labeling, medical writing, quality, records management, and safety and regulatory alliance management. -
Head, Regulatory Affairs Information And OperationsBiogen Feb 2015 - Oct 2018Headed 35-employee global regulatory information and operations organization comprised of regulatory operations, regulatory quality, and R&D records management teams, including centralized trial master file (TMF) function. Interim Head of Clinical Trial Applications (CTA) and Medical Writing. -
Head, Regulatory Affairs, CmcBiogen Apr 2007 - Feb 2015Led the global regulatory affairs chemistry, manufacturing, and controls (CMC) organization comprised of approximately 40 regulatory professionals. Oversaw and contributed to global regulatory CMC strategy and submissions for all marketed and development products from pre-IND through marketing lifecycle management for biologics, small molecules, combination products, and medical devices, including new global marketing applications for five novel products. Supported GMP inspections and controlled document development. Led meetings with global Health Authorities (pre-NDA/BLA, end of phase 2, pre-IND, FDA Type C, Scientific Advice) on CMC topics such as comparability, release testing, container closure changes, devices, facility changes, product recall. -
Director, Regulatory AffairsBiogen Jul 2001 - Apr 2007Led a team accountable for marketed products and products in development. Created and implemented the global regulatory strategy (clinical, pre-clinical, CMC, and labeling) for products in Phase I through post-marketing for multiple indications including filing new drug marketing applications. Led meetings with Health Authorities globally.
Ann Dodds-Frerichs Education Details
-
Master Of Business Administration (M.B.A.)
Frequently Asked Questions about Ann Dodds-Frerichs
What company does Ann Dodds-Frerichs work for?
Ann Dodds-Frerichs works for Dyne Therapeutics
What is Ann Dodds-Frerichs's role at the current company?
Ann Dodds-Frerichs's current role is Biotechnology & Pharmaceutical Leader | Driving Expertise & Impact in Regulatory Affairs, Quality, Compliance, Safety & Business Operations | Strategy | Clinical Excellence.
What schools did Ann Dodds-Frerichs attend?
Ann Dodds-Frerichs attended University Of Maryland College Park, Virginia Polytechnic Institute And State University.
Who are Ann Dodds-Frerichs's colleagues?
Ann Dodds-Frerichs's colleagues are Esther Aix, Ph.d., Si Han Li, Jennifer Johnson, Suhas Bhat Mulki, Rosa Martinez, Maria Gilliam, Shikha Grover, Ph.d..
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial